We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biogen Alleges New York Firm Copied its Alzheimer’s Candidate
Biogen Alleges New York Firm Copied its Alzheimer’s Candidate
Biogen has filed suit against New York-based Creative Biolabs, claiming that the company has been copying its patented Alzheimer’s drug candidate aducanumab and selling imitation products to researchers online.